Danish dermatology firm Leo Pharma is cutting 200 jobs, its fourth reduction since 2022. Under CEO Christophe Bourdon, the ...

California-based AI firm Suki has raised $70 million in new funding, led by Hedosophia, bringing its total to $165 million.

Switzerland-based KeyBioscience and US pharma major Eli Lilly have extended their collaboration on dual amylin calcitonin ...

Swiss generic and biosimilar medicines major Sandoz today announced that it has launched a generic paclitaxel formulation in ...

Pfizer is set to present initial findings from its CULTIVATE study of Velsipity (etrasimod) in Crohn’s disease (CD) at UEG ...

The UK's MHRA has approved Pfizer and BioNTech's updated COVID-19 vaccine, Comirnaty (KP.2), for use in adults. This approval ...

The Food and Drug Administration (FDA) approved Genentech's Itovebi (inavolisib), in combination with palbociclib (Ibrance) ...

Berlin, Germany-based Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines ...

German cancer specialist Immatics has priced a $150 million public offering with Jefferies, BofA Securities, and Leerink as ...

South Korea’s Samsung Bioepis has released its Fourth Quarter 2024 Biosimilar Market Report, marking the seventh-edition of ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...